Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Influenza vaccine + Endocine
- Development stage
- Preclinical
- Lead developer
- GSK
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intranasal, Injectable
01
Overview
Influenza vaccines are immunizations designed to prevent infection by the influenza virus. They work by stimulating the immune system to produce antibodies against specific strains of the virus predicted to be most prevalent each year. Influenza vaccines can be inactivated (killed virus) or recombinant (produced using genetic engineering), and are administered annually due to changing viral strains and waning immunity[4][5]. Endocine is an adjuvant—a substance added to some vaccines to enhance the body's immune response. The combination of an influenza vaccine with Endocine aims to improve immunogenicity compared with standard formulations. This approach is under investigation for its potential benefits in increasing antibody production and broadening protection against various flu strains.
- Other names
- flu shot + endocineinactivated influenza vaccine + endocinerecombinant influenza vaccine + endocine
02
Targets
PSMB9 (Immunoproteasome subunit beta type-1i)
Beyond the preview
Go deeper on Influenza vaccine + Endocine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Influenza vaccine + Endocine.